Kusum Harjai

Prof. Dr. Kusum Harjai


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2024 in Fitoterapia
Verified
Journal Article
Closed access
PRPrerna
Prerna
JCJatin Chadha
Jatin Chadha
LKLavanya Khullar
Lavanya Khullar
UMUmang Mudgil
Umang Mudgil
KHKusum Harjai
Kusum Harjai

24 June 2024 in Archives of Microbiology
Verified
Journal Article
Closed access
PDF file
JCJatin Chadha
Jatin Chadha
PAPrerna Ahuja
Prerna Ahuja
UMUmang Mudgil
Umang Mudgil
LKLavanya Khullar
Lavanya Khullar
KHKusum Harjai
Kusum Harjai

3 December 2023 in Microbial Pathogenesis
Verified
Journal Article
Closed access
GMGaurav Moudgil
Gaurav Moudgil
JCJatin Chadha
Jatin Chadha
LKLavanya Khullar
Lavanya Khullar
SCSanjay Chhibber
Sanjay Chhibber
KHKusum Harjai
Kusum Harjai

6 December 2022 in Life Sciences
Verified
Journal Article
Closed access
JCJatin Chadha
Jatin Chadha
RARavi
Ravi
JSJogender Singh
Jogender Singh
KHKusum Harjai
Kusum Harjai

28 November 2023 in Microbial Pathogenesis
Verified
Journal Article
Closed access
JCJatin Chadha
Jatin Chadha
LKLavanya Khullar
Lavanya Khullar
PGPallavi Gulati
Pallavi Gulati
SCSanjay Chhibber
Sanjay Chhibber
KHKusum Harjai
Kusum Harjai

16 May 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
PNPreeti Negi
Preeti Negi
JCJatin Chadha
Jatin Chadha
KHKusum Harjai
Kusum Harjai
VGVijay Singh Gondil
Vijay Singh Gondil
SKSeema Kumari
Seema Kumari
KRKhem Raj
Khem Raj
Hospital-acquired infections (HAIs) pose a significant risk to global health, impacting millions of individuals globally. These infections have increased rates of morbidity and mortality due to the prevalence of widespread antimicrobial resistance (AMR). Graphene-based nanoparticles (GBNs) are known to possess extensive antimicrobial properties by inflicting damage to the cell membrane, suppressing virulence, and inhibiting microbial biofilms. Developing alternative therapies for HAIs and addressing AMR can be made easier and more affordable by combining nanoparticles with medicinal plants harboring antimicrobial properties. Hence, this study was undertaken to develop a novel graphene–silver nanocomposite via green synthesis using Trillium govanianum plant extract as a reducing agent. The resulting nanocomposite comprised silver nanoparticles embedded in graphene sheets. The antibacterial and antifungal properties of graphene–silver nanocomposites were investigated against several nosocomial pathogens, namely, Candida auris, Candida glabrata, Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, and Pseudomonas aeruginosa. The nanocomposite displayed broad-range antimicrobial potential against the test pathogens, with minimum inhibitory concentrations (MICs) ranging between 31.25 and 125.0 µg/mL, and biofilm inhibition up to 80–96%. Moreover, nanocomposite-functionalized urinary catheters demonstrated hemocompatibility towards sheep erythrocytes and imparted anti-fouling activity to the biomaterial, while also displaying biocompatibility towards HEK 293 cells. Collectively, this investigation highlights the possible application of green-synthesized GBNs as an effective alternative to conventional antibiotics for combating multidrug-resistant pathogens.